MWNA
SIOX

Marshall Wace North America’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Marshall Wace North America’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-88,267
Closed -$452K – 1700
2019
Q4 		$452K Sell
88,267
-476
-0.5% -$2.64K ﹤0.01% 843
2019
Q3 		$573K Buy
+88,743
New +$612K ﹤0.01% 793
2019
Q2 		– Sell
-1,466
Closed -$16K – 1750
2019
Q1 		$16K Hold
1,466
– – ﹤0.01% 1413
2018
Q4 		$12K Sell
1,466
-1,322
-47% -$19.1K ﹤0.01% 1413
2018
Q3 		$54K Sell
2,788
-55,294
-95% -$1.01M ﹤0.01% 880
2018
Q2 		$1.05M Buy
+58,082
New +$857K 0.01% 917
2018
Q1 		– Sell
-2,438
Closed -$103K – 1776
2017
Q4 		$103K Hold
2,438
– – ﹤0.01% 1312
2017
Q3 		$137K Buy
+2,438
New +$411K ﹤0.01% 1193

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $581M AUM 108.65% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return